Form 4 · Filed Feb 4, 2026, 12:00 PM UTC
OLMA/Olema Pharmaceuticals, Inc.
Zojwalla Naseem — CHIEF MEDICAL OFFICER
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | A | other | 250,000 | $0 | — | 250,000 |
| Feb 2, 2026 | A | other | 106,250 | $0 | — | 106,250 |
Source: SEC EDGAR raw filing ↗ · Accession 0001905871-26-000002